Clinical trial
A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients
NCT02661100
Study timeline
Study start (unknown)2017-01-01Date precision: month
Registry last updated2016-12-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancerunresolved
Advanced Triple Negative Breast Cancerunresolved
Small Cell Lung Cancerunresolved
Urothelial Cancerunresolved
Mesotheliomaunresolved
Malignant Melanomaunresolved
Interventions
Sponsors & collaborators
Case Comprehensive Cancer Centerlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02661100 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.